Vermont

In Review: PCMA testified in the Senate Committee on Finance, expressing our concerns about H 233, the bill to ban spread pricing, and the private right of action. PCMA followed up with Senator Kesha Hinsdale (D) on the issues with

In Review: The Senate Finance Committee held a preliminary hearing on H 233, which is a ban on spread pricing, private right of action, and copay coupons being applied to a patient’s deductible. The hearing was a walkthrough of the

In Review: PCMA testified in the Senate Health and Welfare Committee on H 233, which is a ban on spread pricing, private right of action, and copay coupons being applied to deductibles. After the hearing, an amendment was proposed by

Up Next: The Senate Health and Welfare Committee will hold a hearing on Tuesday, April 16, on H 233, which is a ban on spread pricing, creating a private right of action, and a ban on copay coupons being applied

In Review: The Senate Health and Welfare Committee held a hearing on H 233, which would ban spread pricing, give the attorney general a private right of action on PBMs, and allow copay coupons to be applied to a patient’s

In Review: The House Health Care Committee voted to pass their PBM bill, which would include a ban on spread, copay coupons to apply to a patient’s deductible, a private right of action, and rebates to be offered at the

In Review: PCMA testified in the House Committee on Health Care on a bill to ban spread pricing, requiring rebates to be offered at the point-of-sale and a private right of action for pharmacies against a PBM. PCMA is following

Up Next: The House Committee on Health Care will have a hearing on Wednesday, January 31, to discuss H 766. H 766 deals with prior authorizations and copay coupons applied to a patient’s deductible. PCMA will participate in the Wednesday